Walgreens Boots Alliance, Inc. WBA
Set alert
11.98 0.00 0.00%
At close · Aug 28
11.98 Day range 11.98
8.08 52-week range 13.25
- YTD
- +28.40%
- 1 year
- +26.77%
- Open
- 11.98
- Prev close
- 11.98
- Mkt cap
- 10.37B
- Vol
- 452.08M
- Avg vol
- 16.12M
- EPS
- -7.29
- P/E
- 7.09
- Div yield
- 8.35%
More statistics
- Low
- 11.98
- High
- 11.98
- Forward P/E
- 8.15
- Beta
- 0.77
- Short ratio
- 3.35
- Inst. own
- 60.94%
- Dividend
- 1.00
- Ex-div date
- Nov 17, 2024
- Earnings
- Oct 21, 2025
- 50-d avg
- 11.68
- 200-d avg
- 10.90
- 1y target
- 12.11
2Y chart
Events in this range
- Nov 13, 2023Dividend: 0.48
- Feb 16, 2024Dividend: 0.25
- Feb 20, 2024Dividend: 0.25
- May 20, 2024Dividend: 0.25
- Jun 27, 2024Earnings: —; estimate 0.67; surprise —%
- Aug 21, 2024Dividend: 0.25
- Oct 15, 2024Earnings: —; estimate 0.36; surprise —%
- Nov 18, 2024Dividend: 0.25
- Jan 10, 2025Earnings: —; estimate 0.37; surprise —%
- Jan 13, 2025Rating: B of A Securities · Underperform → Underperform
- Jan 13, 2025Rating: Evercore ISI Group · In-Line → In-Line
- Jan 15, 2025Rating: RBC Capital · Sector Perform → Sector Perform
- Jan 16, 2025Rating: Truist Securities · Hold → Hold
- Jan 31, 2025Rating: Truist Securities · Hold → Hold
- Feb 28, 2025Downgrade: Deutsche Bank · Hold → Sell
- Apr 8, 2025Earnings: —; estimate 0.53; surprise —%
- Jun 26, 2025Earnings: —; estimate 0.34; surprise —%
Signals (92)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Aug 26, 2025 | 1 year ago |
| RSI: Overbought | Aug 4, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 28, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 20, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 10, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 7, 2025 | 1 year ago |
| SMA: Bearish | May 6, 2025 | 1 year ago |
| SMA: Bearish | May 1, 2025 | 1 year ago |
| SMA: Bullish | Apr 30, 2025 | 1 year ago |
| SMA: Bearish | Apr 29, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 23, 2025 | 1 year ago |
| SMA: Bullish | Apr 11, 2025 | 1 year ago |
| SMA: Bearish | Apr 10, 2025 | 1 year ago |
| SMA: Bullish | Apr 9, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 21, 2025 | 1 year ago |
| SMA: Bullish | Mar 7, 2025 | 1 year ago |
| SMA: Bullish | Mar 4, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| SMA: Bearish | Feb 28, 2025 | 1 year ago |
| SMA: Bullish | Feb 27, 2025 | 1 year ago |
| SMA: Bearish | Feb 26, 2025 | 1 year ago |
| SMA: Bullish | Feb 25, 2025 | 1 year ago |
| SMA: Bullish | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 21, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 19, 2025 | 1 year ago |
| SMA: Bullish | Feb 18, 2025 | 1 year ago |
| SMA: Bearish | Feb 6, 2025 | 1 year ago |
| SMA: Bullish | Feb 5, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 28, 2025 | 1 year ago |
| SMA: Bearish | Jan 21, 2025 | 1 year ago |
| SMA: Bullish | Jan 14, 2025 | 1 year ago |
| RSI: Overbought | Jan 13, 2025 | 1 year ago |
| SMA: Bullish | Jan 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 10, 2025 | 1 year ago |
| SMA: Bearish | Jan 8, 2025 | 1 year ago |
| SMA: Bullish | Jan 3, 2025 | 1 year ago |
| SMA: Bearish | Jan 2, 2025 | 1 year ago |
| SMA: Bullish | Dec 31, 2024 | 1 year ago |
| SMA: Bearish | Dec 30, 2024 | 1 year ago |
| SMA: Bullish | Dec 26, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 24, 2024 | 1 year ago |
| SMA: Bearish | Dec 23, 2024 | 1 year ago |
| SMA: Bullish | Dec 10, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 27, 2024 | 1 year ago |
| SMA: Bearish | Nov 12, 2024 | 1 year ago |
| SMA: Bullish | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Nov 8, 2024 | 1 year ago |
| SMA: Bullish | Oct 31, 2024 | 2 years ago |
| SMA: Bearish | Oct 30, 2024 | 2 years ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 25, 2024 | 2 years ago |
| SMA: Bearish | Oct 23, 2024 | 2 years ago |
| RSI: Overbought | Oct 16, 2024 | 2 years ago |
| SMA: Bullish | Oct 15, 2024 | 2 years ago |
| RSI: Oversold | Sep 25, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 12, 2024 | 2 years ago |
| RSI: Oversold | Sep 10, 2024 | 2 years ago |
| RSI: Oversold | Aug 28, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 27, 2024 | 2 years ago |
| RSI: Oversold | Aug 12, 2024 | 2 years ago |
| RSI: Oversold | Jul 19, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 16, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 27, 2024 | 2 years ago |
| RSI: Oversold | Jun 27, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 6, 2024 | 2 years ago |
| RSI: Oversold | May 28, 2024 | 2 years ago |
| MACD: Sell Signal | May 22, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 22, 2024 | 2 years ago |
| RSI: Oversold | Apr 15, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 2, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 8, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 13, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 12, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 9, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 6, 2024 | 2 years ago |
| SMA: Bearish | Jan 16, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 4, 2024 | 2 years ago |
| RSI: Overbought | Jan 2, 2024 | 2 years ago |
| RSI: Overbought | Dec 21, 2023 | 2 years ago |
| RSI: Overbought | Dec 13, 2023 | 2 years ago |
| SMA: Bullish | Dec 7, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 4, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 27, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 15, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 9, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 3, 2023 | 2 years ago |
| MACD: Sell Signal | Oct 20, 2023 | 3 years ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 39.67B
- Trailing P/E
- 0.00
- Forward P/E
- 8.15
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.44
- EPS (TTM)
- -7.29
- Beta
- 0.77
- Dividend yield
- 8.35%
- Payout ratio
- 290.91%
- Profit margin
- -4.07%
- Revenue (TTM)
- 154.58B
- Revenue growth
- 7.20%
- Free cash flow
- 4.52B
- Total cash
- 830.00M
- Total debt
- 30.00B
- Return on equity
- -69.58%
- Shares outstanding
- 865.56M
- Short % of float
- 3.58%
- 50-day average
- 11.68
- 200-day average
- 10.90
Analyst view
Consensus: hold
Hold
Price target (mean) 12.11 +1.1% upside
Now 11.98
- Target (low)
- 11.00
- Target (mean)
- 12.11
- Target (high)
- 15.00
Ratings (0m) 8 1 buy · 7 hold · 0 sell
- Strong buy0
- Buy1
- Hold7
- Sell0
- Strong sell0
Next earnings
Oct 21, 2025
Expected Oct 21, 2025. Consensus EPS estimate 0.25901.
Financials — quick view
WBA Revenue — quarterly 38.99B
WBA Net income — quarterly -175.00M
WBA EPS — quarterly -0.20
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 21, 2025 | Aug 1, 2025 | 0.27 | — | — | — |
| Jun 26, 2025 | May 1, 2025 | 0.34 | — | — | — |
| Apr 8, 2025 | Feb 1, 2025 | 0.53 | — | — | — |
| Jan 10, 2025 | Nov 1, 2024 | 0.37 | — | — | — |
| Oct 15, 2024 | Aug 1, 2024 | 0.36 | — | — | — |
| Jun 27, 2024 | May 1, 2024 | 0.67 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 28, 2025 | Deutsche Bank | down | Hold | Sell |
| Jan 31, 2025 | Truist Securities | main | Hold | Hold |
| Jan 16, 2025 | Truist Securities | main | Hold | Hold |
| Jan 15, 2025 | RBC Capital | main | Sector Perform | Sector Perform |
| Jan 13, 2025 | Evercore ISI Group | main | In-Line | In-Line |
| Jan 13, 2025 | B of A Securities | main | Underperform | Underperform |
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Country
- United States
- Website
- walgreensbootsalliance.com
News
- A Sinking Ship or A Turnaround Bet
- US pharmacy chain Walgreens plans tech centre in India's Chennai, expected to create 250 jobs
- Walgreens Pharmacists Help Medicare Patients Navigate New Access to GLP‑1 Medications
- Walgreens Boosts Pharmacy Access with Expanded Hours on 4th of July
- Walgreens Helps FIFA World Cup™ Fans in Miami Stay Game-Ready with Pharmacy Care and Everyday Essentials
- Walgreens Helps FIFA World Cup™ Fans in Dallas Stay Game-Ready with Pharmacy Care and Everyday Essentials
- Walgreens Helps FIFA World Cup™ Fans in Houston Stay Game-Ready with Pharmacy Care and Everyday Essentials
- Walgreens Helps FIFA World Cup™ Fans in Atlanta Stay Game-Ready with Pharmacy Care and Everyday Essentials
- Walgreens Helps FIFA World Cup™ Fans in Seattle Stay Game-Ready with Pharmacy Care and Everyday Essentials
- Walgreens Helps FIFA World Cup™ Fans in New York Stay Game-Ready with Pharmacy Care and Everyday Essentials
Your note
Sign in to keep a note on WBA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FABBRI BETH AMBER L. | Officer | Stock Award(Grant) | Oct 31, 2024 | 123,130 |
| GATES RICHARD P | Officer | Stock Award(Grant) | Oct 31, 2024 | 141,520 |
| HANSON BRYAN C | Director | Stock Award(Grant) | Aug 12, 2025 | 47,655 |
| HECKMAN TODD | Officer | Stock Award(Grant) | Oct 31, 2024 | 92,350 |
| LANGOWKSI MARY | Officer | Stock Award(Grant) | Oct 31, 2024 | 519,600 |
| MAHAJAN MANMOHAN LAL | Officer | Stock Award(Grant) | Oct 31, 2024 | 414,064 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 9.60% | 83,119,485 | 995.77M | Jun 29, 2025 |
| Blackrock Inc. | 5.93% | 51,366,742 | 615.37M | Jun 29, 2025 |
| State Street Corporation | 3.73% | 32,243,219 | 386.27M | Jun 29, 2025 |
| Invesco Ltd. | 2.67% | 23,141,239 | 277.23M | Jun 29, 2025 |
| FMR, LLC | 2.57% | 22,216,576 | 266.15M | Jun 29, 2025 |
| FIL LTD | 2.38% | 20,609,000 | 246.90M | Jun 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.58% | 22,292,701 | 267.07M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.35% | 20,372,818 | 244.07M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.96% | 16,931,841 | 202.84M | Jun 29, 2025 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 1.46% | 12,597,549 | 150.92M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.25% | 10,813,864 | 129.55M | Jun 29, 2025 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.05% | 9,094,105 | 108.95M | Jun 29, 2025 |